Incidence of Gastrointestinal neuroendocrine tumors (GI-NETs)
The incidence of Gastrointestinal neuroendocrine tumors (GI-NETs) has been increasing in recent years.
Gastric NETs (G-NETs) are classified into three distinct subgroups: type I, II, and III.
Type I G-NETs are the most common subtypes and are associated with chronic atrophic gastritis, (autoimmune gastritis and Helicobacter pylori-associated atrophic gastritis).
Type II G-NETs are associated with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome.
Endoscopic resection and follow-up are amenable treatment options for most type I and II G-NETs.
In contrast, type III G-NETs are large-sized single tumors and are usually malignant. Therefore, surgical resection and chemotherapy are generally necessary for type III G-NETs.
Here, we demonstrate a recent case presenting with multiple Gastric NETs (low grade with no metastasis) who underwent complete margin-free endoscopic resection using EMR for smaller and ESD for larger NET.
To know more videos related to Endoscopy and colonoscopy
What is Endoscopy? Click on the link - https://www.youtube.com/watch?v=k1Ov7nAKn94
Are Endoscopy and Colonoscopy considered surgery? Click on the link - https://www.youtube.com/watch?v=VP0bD67SExY
Is Endoscopy Painful? What happens during an endoscopy? Click on the link - https://www.youtube.com/watch?v=PMdNR-j_RTc
Dr. Shrihari Anikhindi is a Gastroenterologist and Hepatologist at Sir Ganga Ram Hospital and Medigest, New Delhi.
Visit our Website - http://medigest.in/
Also, follow us on -
Instagram - https://www.instagram.com/medigestcare/
Facebook - https://www.facebook.com/medigestcare
Pinterest - https://in.pinterest.com/medigestcare/
No comments found